Recombinant Human Putative uncharacterized protein FLJ37107 is a 131 amino acid protein identified through genomic sequencing with UniProt ID Q8N9I1. As recombinant protein, it is typically expressed in bacterial systems with an N-terminal His-tag for purification purposes. The protein is currently classified as "uncharacterized," indicating its biological function remains largely unknown and presents an opportunity for novel research discovery .
When working with uncharacterized proteins, researchers should approach them as potential participants in any biological pathway. Initial characterization typically involves sequence analysis, structural prediction, expression pattern analysis, and preliminary functional assays based on predicted domains.
The recombinant FLJ37107 protein is typically expressed in E. coli expression systems with an N-terminal His-tag to facilitate purification. This approach enables relatively high protein yields while maintaining cost-effectiveness for research purposes. The bacterial expression system may lack some post-translational modifications that would be present in mammalian cells, which should be considered when designing experiments .
For researchers investigating this protein, it's important to note that alternative expression systems (mammalian, insect, or cell-free) might provide different structural or functional characteristics, especially if post-translational modifications are suspected to play a role in the protein's function.
The recommended reconstitution protocol for lyophilized FLJ37107 involves:
Centrifuging the vial briefly to ensure all powder is at the bottom
Reconstituting in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Adding glycerol to a final concentration of 5-50% (50% is the standard recommendation)
Aliquoting the solution for long-term storage at -20°C/-80°C to avoid repeated freeze-thaw cycles
This method helps maintain protein stability and activity. When reconstituting any recombinant protein, it's crucial to avoid vigorous shaking or vortexing, which can cause protein denaturation. Gentle pipetting is recommended until the protein is fully dissolved .
Multiple analytical techniques should be employed to validate the quality of recombinant FLJ37107:
SDS-PAGE to confirm molecular weight and initial purity assessment
Western blotting using anti-His antibodies to verify expression of the full-length His-tagged protein
Mass spectrometry for precise molecular weight determination and identification of any modifications
Size exclusion chromatography to assess aggregation state and homogeneity
Circular dichroism to evaluate secondary structure formation
Dynamic light scattering to analyze size distribution and potential aggregation
For uncharacterized proteins, comparing experimental results with theoretical predictions from sequence analysis provides valuable validation information. Documentation of multiple quality control parameters establishes a foundation for reproducible experimental findings .
When designing stability studies for FLJ37107, researchers should consider:
Temperature stability: Test protein integrity after storage at different temperatures (-80°C, -20°C, 4°C, and room temperature) over various time points (24 hours, 1 week, 1 month)
pH stability: Evaluate protein in buffers ranging from pH 5.0 to 9.0 to determine optimal range for maintaining activity
Buffer composition effects: Test various buffering agents (Tris, phosphate, HEPES) and additives (glycerol, reducing agents, salt concentrations)
Freeze-thaw stability: Assess protein integrity after multiple freeze-thaw cycles using SDS-PAGE and activity assays
Long-term storage conditions: Compare lyophilized versus solution storage
For uncharacterized proteins like FLJ37107, stability studies are particularly important as they provide foundational information for all subsequent functional characterization experiments. Tracking changes in both structural integrity (via SDS-PAGE) and functional activities is essential for comprehensive stability assessment.
Multiple bioinformatic approaches should be employed to predict potential functions of FLJ37107:
Sequence homology analysis: Employ BLAST, HMMER, and PSI-BLAST to identify similar proteins with known functions
Domain prediction: Use tools like SMART, Pfam, and PROSITE to identify functional domains or motifs
Gene Ontology enrichment: Analyze GO terms associated with proteins showing sequence similarity
Protein-protein interaction prediction: Apply STRING, STITCH or BioGRID to predict potential interaction partners
Structural modeling: Use I-TASSER, Phyre2, or AlphaFold2 to predict tertiary structure and functional sites
Phylogenetic analysis: Construct evolutionary trees to identify conservation patterns across species
Expression correlation analysis: Analyze public transcriptomic datasets to identify genes with correlated expression patterns
The combined results from these approaches can generate testable hypotheses about FLJ37107 function. For instance, the presence of hydrophobic regions in the amino acid sequence suggests potential membrane association, which could be further investigated with more specific predictive tools for transmembrane domains or membrane localization signals .
To determine cellular localization of FLJ37107, researchers should employ multiple complementary techniques:
Fluorescent fusion protein approach:
Create N- and C-terminal GFP or mCherry fusion constructs
Express in relevant cell lines and visualize using confocal microscopy
Co-localize with established organelle markers (mitochondria, ER, Golgi, etc.)
Subcellular fractionation:
Separate cellular components (membrane, cytosol, nucleus, etc.)
Detect FLJ37107 in fractions using Western blotting
Compare distribution with known marker proteins for each fraction
Immunofluorescence microscopy:
Generate specific antibodies against FLJ37107
Perform immunostaining in fixed cells
Use super-resolution microscopy for detailed localization
Proximity labeling methods:
Create BioID or APEX2 fusion constructs with FLJ37107
Identify neighboring proteins through mass spectrometry
Infer localization from known locations of proximal proteins
When working with uncharacterized proteins, it's crucial to use multiple approaches as each method has inherent limitations. Additionally, testing localization in multiple cell types can reveal cell-specific variations in protein distribution that may provide functional insights.
To identify potential interaction partners of FLJ37107, researchers should consider implementing these methodologies:
Affinity purification-mass spectrometry (AP-MS):
Use His-tagged FLJ37107 as bait protein
Perform pull-down experiments from cell lysates
Identify co-purifying proteins using mass spectrometry
Validate with reciprocal pull-downs
Yeast two-hybrid screening:
Use FLJ37107 as bait against human cDNA libraries
Screen for positive interactions using reporter gene activation
Validate with secondary assays such as co-immunoprecipitation
Proximity-dependent biotinylation (BioID/TurboID):
Express FLJ37107 fused to a biotin ligase
Identify proximal proteins that become biotinylated
Analyze biotinylated proteins by mass spectrometry
Cross-linking mass spectrometry:
Use chemical crosslinkers to capture transient interactions
Identify crosslinked peptides by specialized mass spectrometry approaches
Map interaction interfaces at amino acid resolution
Co-localization studies:
Fluorescently tag FLJ37107 and suspected partners
Analyze co-localization using confocal microscopy
Quantify using Pearson's correlation coefficient
When investigating uncharacterized proteins like FLJ37107, it's particularly important to include appropriate controls to distinguish specific interactions from background. Performing experiments under different conditions (cell types, stressors, differentiation states) can reveal context-dependent interactions that provide functional insights.
For investigating potential functions of uncharacterized proteins like FLJ37107, researchers should consider multiple cell-based approaches:
Gene silencing/knockout studies:
Use siRNA, shRNA, or CRISPR-Cas9 to reduce or eliminate FLJ37107 expression
Assess effects on cell morphology, proliferation, migration, and survival
Perform RNA-seq to identify affected pathways
Overexpression studies:
Create stable or inducible cell lines expressing FLJ37107
Analyze phenotypic changes compared to control cells
Examine effects on known signaling pathways using reporter assays
Cellular stress response:
Subject FLJ37107-modified cells to various stressors (oxidative stress, nutrient deprivation, etc.)
Assess changes in sensitivity compared to control cells
Identify stress conditions where FLJ37107 becomes particularly important
Differentiation assays:
Examine the role of FLJ37107 during cellular differentiation processes
Monitor expression changes during differentiation timecourses
Assess impact of FLJ37107 modulation on differentiation markers
Cell fractionation with activity assays:
Isolate subcellular fractions containing FLJ37107
Test for enzymatic activities based on bioinformatic predictions
Compare activity with and without recombinant FLJ37107 supplementation
For uncharacterized proteins, it's recommended to start with broad phenotypic assays before narrowing to more specific functional tests based on initial findings. Since the hydrophobic regions in FLJ37107 suggest potential membrane association, assays examining membrane integrity or transport functions might be particularly revealing .
When working with recombinant versions of uncharacterized proteins like FLJ37107, researchers should implement these strategies to minimize artifacts:
Tag interference assessment:
Compare N-terminal versus C-terminal tagged versions
Include tag-only controls in all experiments
Consider using cleavable tags to remove them after purification
Validate key findings with untagged protein when possible
Expression system considerations:
Compare E. coli-expressed protein with mammalian-expressed versions
Assess glycosylation state using glycosidase treatments
Check for proper disulfide bond formation in bacterial expressions
Contamination control:
Implement rigorous host cell protein (HCP) analysis
Use multiple purification steps to ensure high purity
Include buffer-only and irrelevant protein controls
Aggregation monitoring:
Analyze by dynamic light scattering before experiments
Perform size exclusion chromatography to ensure monodispersity
Use negative stain electron microscopy to visualize protein state
Endotoxin testing:
For cell-based experiments, verify endotoxin levels are below threshold
Include polymyxin B controls to neutralize potential endotoxin effects
A systematic approach to validating that observed effects are specifically due to FLJ37107 rather than experimental artifacts is essential, particularly for uncharacterized proteins where unexpected functions may be discovered .
To investigate post-translational modifications (PTMs) of FLJ37107, researchers should employ multiple complementary techniques:
Mass spectrometry-based approaches:
Perform bottom-up proteomics with multiple proteases
Use enrichment strategies for specific PTMs (phosphorylation, glycosylation)
Employ electron transfer dissociation for PTM site localization
Compare PTM patterns between recombinant and endogenous protein
Gel-based detection:
Use Pro-Q Diamond for phosphorylation detection
Apply periodic acid-Schiff staining for glycosylation
Perform 2D gel electrophoresis to separate protein isoforms
Enzymatic treatments:
Test sensitivity to phosphatases, glycosidases, or deubiquitinases
Monitor mobility shifts before and after treatments
Quantify release of modification groups
Site-directed mutagenesis:
Mutate predicted modification sites (Ser, Thr, Tyr for phosphorylation)
Assess impact on protein function and localization
Compare wild-type and mutant protein behavior
Specific PTM antibodies:
Use modification-specific antibodies (phospho, acetyl, etc.)
Perform Western blotting before and after enzymatic treatments
Validate with immunoprecipitation followed by mass spectrometry
Since FLJ37107 is currently expressed in E. coli systems, which lack mammalian PTM machinery, comparing the recombinant protein with endogenously expressed protein can reveal important functional modifications that may be missing in the bacterial system .
When confronting conflicting results in FLJ37107 research, implement this systematic approach:
Experimental variable analysis:
Create a comprehensive table documenting all experimental conditions
Identify subtle differences in protein preparation, concentration, buffers
Systematically test each variable's impact on outcomes
Cell line and context dependence:
Verify findings across multiple cell lines
Test under different physiological conditions (serum starvation, confluence)
Consider tissue-specific effects if contradictions occur between systems
Technical validation:
Employ orthogonal techniques to verify key findings
Increase biological and technical replicates
Perform power analysis to ensure adequate sample sizes
Collaborative verification:
Engage independent laboratories to reproduce critical experiments
Share detailed protocols and reagents to ensure comparability
Document all protocol variations when comparing results
Literature reconciliation:
Create a structured database of published findings
Classify results based on experimental systems and conditions
Identify patterns that might explain apparent contradictions
For uncharacterized proteins like FLJ37107, conflicting results often ultimately lead to discoveries about context-dependent functions or multiple molecular roles. Approaching contradictions as opportunities for deeper understanding rather than experimental failures can yield valuable insights.
When analyzing experimental data for uncharacterized proteins like FLJ37107, employ these statistical approaches:
For expression analysis:
Use paired t-tests for before/after comparisons within same samples
Apply ANOVA with post-hoc tests for multi-condition experiments
Implement non-parametric alternatives (Mann-Whitney, Kruskal-Wallis) when normality cannot be assumed
For interaction studies:
Calculate enrichment scores relative to control pull-downs
Apply false discovery rate corrections for mass spectrometry data
Use permutation tests to establish significance thresholds
For functional assays:
Employ dose-response curve fitting for concentration-dependent effects
Use regression analysis to identify correlations between protein levels and phenotypes
Apply mixed-effects models when examining data across multiple cell lines
For omics integration:
Implement pathway enrichment analysis for RNA-seq after FLJ37107 perturbation
Use principal component analysis to identify major sources of variation
Apply network analysis to position FLJ37107 within interaction landscapes
For reproducibility assessment:
Calculate intraclass correlation coefficients between replicates
Perform Bland-Altman analysis for method comparisons
Use bootstrapping approaches to estimate confidence intervals
When working with an uncharacterized protein, robust statistical approaches that account for biological variability are essential. Given the potential for unexpected functions, statistical methods should balance sensitivity (to detect novel effects) with specificity (to avoid false positives).
To investigate the in vivo function of FLJ37107 using animal models, researchers should consider this comprehensive approach:
Expression profiling across tissues and developmental stages:
Use RT-qPCR, in situ hybridization, and immunohistochemistry
Create reporter animals (knock-in of fluorescent protein)
Establish tissue and temporal expression patterns
Loss-of-function models:
Generate conventional knockout models
Develop conditional knockout systems (Cre-loxP) for tissue-specific deletion
Create inducible knockout systems for temporal control
Apply CRISPR-Cas9 for rapid generation of multiple alleles
Gain-of-function models:
Develop transgenic overexpression lines
Create knock-in models with constitutively active mutations
Establish inducible expression systems
Phenotypic analysis pipeline:
Perform comprehensive phenotyping (behavior, physiology, histology)
Use -omics approaches (transcriptomics, proteomics, metabolomics)
Conduct challenge studies (stress tests, disease models)
Examine aging effects and lifespan impacts
Humanized models:
Replace mouse FLJ37107 with human version
Assess functional conservation or divergence
Test human variants of unknown significance
When studying uncharacterized proteins like FLJ37107, beginning with careful expression profiling can guide subsequent functional studies by identifying tissues where the protein may have critical roles. Combining multiple model organisms (zebrafish, mice) can provide complementary insights and validation.
When designing quasi-experimental studies for investigating FLJ37107 function, researchers should consider:
Study design selection:
Choose higher-quality designs from the hierarchy of quasi-experimental approaches
Consider repeated-treatment designs (O1 X O2 removeX O3 X O4) to demonstrate causality
Implement non-equivalent dependent variable designs where appropriate
Use time-series designs when investigating dynamic processes
Controlling for confounding variables:
Identify and measure potential confounding factors
Use statistical controls and matching techniques
Implement propensity score methods for observational data
Consider instrumental variable approaches when randomization is impossible
Internal validity enhancement:
Include multiple control groups when feasible
Conduct sensitivity analyses for key assumptions
Implement difference-in-differences approaches
Use interrupted time series analysis for temporal data
Statistical power considerations:
Perform a priori power analyses based on expected effect sizes
Consider clustered or hierarchical data structures in calculations
Plan for potential attrition or missing data
Determine appropriate sample sizes for subgroup analyses
Reporting and transparency:
Document all methodological decisions and their rationales
Pre-register study designs and analysis plans
Report all measured variables and outcomes
Discuss threats to internal and external validity
For studies of uncharacterized proteins like FLJ37107, quasi-experimental designs can be particularly valuable when ethical or practical constraints prevent randomized experiments. The removed-treatment design can be especially informative as it allows testing hypotheses about outcomes in both the presence and absence of interventions .
For comprehensive characterization of FLJ37107 using mass spectrometry, researchers should employ these specialized approaches:
Intact protein analysis (top-down proteomics):
Perform high-resolution MS analysis of the intact protein
Measure exact molecular weight and identify proteoforms
Use electron-capture dissociation for fragment analysis
Compare theoretical and experimental masses to identify modifications
Hydrogen-deuterium exchange MS (HDX-MS):
Map solvent-accessible regions of the protein
Identify potential binding interfaces
Monitor structural changes under different conditions
Compare experimental conditions to detect conformational shifts
Cross-linking MS (XL-MS):
Use chemical crosslinkers to capture protein-protein interactions
Apply specialized search algorithms to identify crosslinked peptides
Generate distance constraints for structural modeling
Create interaction maps with partner proteins
Native MS:
Analyze FLJ37107 under non-denaturing conditions
Determine oligomerization state and complex formation
Assess binding of small molecules or cofactors
Examine stability under different buffer conditions
Targeted quantitative MS:
Develop selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) assays
Quantify FLJ37107 expression across tissues or conditions
Monitor specific post-translational modifications
Measure turnover rates using pulse-chase with isotope labeling
These advanced MS techniques provide complementary information about FLJ37107's structure, interactions, and modifications that cannot be obtained through standard proteomic approaches alone. When combined, they create a multi-dimensional view of this uncharacterized protein that can guide functional hypotheses .
Computational modeling can significantly enhance understanding of uncharacterized proteins like FLJ37107 through these approaches:
Structural prediction and analysis:
Apply AlphaFold2 or RoseTTAFold for tertiary structure prediction
Perform molecular dynamics simulations to assess stability
Identify potential binding pockets and functional sites
Compare structural features with functionally characterized proteins
Molecular docking studies:
Screen small molecule libraries for potential binding partners
Model protein-protein interactions with predicted partners
Identify key residues involved in molecular recognition
Guide design of experimental validation studies
Evolutionary analysis:
Construct phylogenetic trees to trace evolutionary history
Identify conserved regions suggesting functional importance
Detect signs of positive selection indicating adaptive evolution
Perform ancestral sequence reconstruction to understand evolutionary trajectory
Multi-scale modeling:
Integrate protein-level models with cellular pathway simulations
Predict phenotypic outcomes of FLJ37107 perturbation
Model dynamics of potential signaling pathways involving FLJ37107
Simulate effects of mutations on protein function
Machine learning approaches:
Apply deep learning to predict protein function from sequence
Use natural language processing to mine literature for related proteins
Develop gene expression-based predictors of FLJ37107 activity
Integrate diverse data types to generate functional hypotheses
Computational approaches are particularly valuable for uncharacterized proteins, as they can generate testable hypotheses that guide experimental design and help prioritize the most promising research directions. The highly hydrophobic C-terminal region of FLJ37107 suggests potential for membrane interaction, which could be specifically modeled to predict orientation and stability in lipid bilayers .